Activation-induced deaminase as a mutator oncogene
Activation-induced deaminase as a mutator oncogene
批准号:
6988888
负责人:
Andrea Bottaro
金额:
$13.42万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2005
资助国家:
美国
项目状态:
已结题
起止时间:
2005-07-01 至 2007-06-30
中文摘要
描述(申请人提供):活化诱导脱氨酶(AID)在正常活化B淋巴细胞中表达,是免疫球蛋白(IG)基因体细胞超突变(SHM)和类别转换重组(CSR)所必需的。虽然AID与RNA编辑酶APOBEC-1具有显著的相似性,但最近的研究结果表明,它可能直接作用于DNA,将胞苷残基改变为尿苷。该应用基于这样的假设,即AID活性调节的丧失导致影响整个基因组的体细胞超突变,而不是高度靶向IG基因。因此,失调的AID可作为致癌基因的突变体,促进肿瘤的发展和进展,特别是在B细胞恶性肿瘤中。支持这一模型的发现是AID在许多人B细胞白血病和淋巴瘤中组成型表达,尽管在这些样品中AID表达通常与IG基因的活性SHM解偶联,表明功能失调。值得注意的是,在B细胞肿瘤样品中可重复地发现可变剪接的AID mRNA,其能够编码缺少被认为参与底物靶向的区域的截短的AID同种型。最后,在转基因小鼠中普遍存在的AID过表达导致T细胞淋巴瘤,但令人惊讶的是,不是B细胞瘤形成。这里假设的功能获得性突变表型代表了一种新的发病机制,并表明AID可能是一个有用的药物干预靶点,以减少肿瘤进展。在这方面,几种已知的和可能的胞苷脱氨酶抑制剂已经被表征,并且可以找到快速的临床应用。基于结构和功能研究,我们预测截短的AID异构体将显示改变的靶向模式,或主要破坏野生型AID的靶向。我们建议具体测试截短的AID同种型对SHM活性的潜在影响,在恶性B细胞中确实是失调的,并研究截短的AID同种型的表达对SHM和CSR活性的影响。为了正式证明AID在B细胞恶性肿瘤中的因果关系,我们将产生新的转基因小鼠,其中AID表达将重现在一些弥漫性大B细胞淋巴瘤中观察到的模式。最后,我们将测试一系列候选药物抑制AID胞苷脱氨酶活性的能力,作为未来靶向药物干预的前奏。
英文摘要
DESCRIPTION (provided by applicant): Activation induced deaminase (AID) is expressed in normal activated B-lymphocytes, where it is required for immunoglobulin (Ig) gene somatic hypermutation (SHM) and class switch recombination (CSR). While AID bears significant similarity to the RNA editing enzyme APOBEC-1, recent findings suggest that it may act directly on DNA, changing cytidine residues into uridine. This application is based on the hypothesis that loss of regulation of AID activity results in somatic hypermutation affecting the entire genome, instead of being highly targeted to Ig genes. As such, deregulated AID could act as a mutator oncogene, contributing to neoplastic development and progression, specifically in B cell malignancies. In support of this model is the finding that AID is constitutively expressed in many human B cell leukemias and lymphomas, although in these samples AID expression is often uncoupled from active SHM of Ig genes, suggesting functional deregulation. Significantly, alternatively spliced AID mRNAs, capable of encoding truncated AID isoforms lacking regions that are thought to be involved in substrate targeting, are reproducibly found in B cell neoplastic samples. Finally, ubiquitous AID overexpression in transgenic mice results in T cell lymphomas, but - surprisingly - not B cell neoplasias. A gain-of-function mutator phenotype as the one hypothesized here would represent a novel pathogenetic mechanism, and would suggest that AID may be a useful target for pharmacological intervention to curtail neoplastic progression. In this respect, several known and likely inhibitors of cytidine deaminases have already been characterized, and could find rapid clinical application. Based on structural and functional studies, we predict that truncated AID isoforms will display altered targeting patterns, or dominantly disrupt targeting of wild-type AID. We propose to specifically test the potential effects of truncated AID isoforms on SHM activity is indeed deregulated in malignant B cells, and to investigate the effect of expression of truncated AID isoforms on SHM and CSR activity. To formally prove the causal involvement of AID in B cell malignancy we will generate new transgenic mice in which AID expression will recapitulate the pattern observed in some diffuse large B cell lymphomas. Finally, we will test a series of drug candidates for their ability to suppress AID cytidine deaminase activity as a prelude to future targeted pharmacological interventions.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Activation-induced deaminase as a mutator oncogene
-
批准号:7140111
-
项目类别:
-
资助金额:$13.1万
-
财政年份:2005
-
负责人:Andrea Bottaro
-
依托单位:
REGULATION OF IGH MU LOCUS CLASS SWITCH RECOMBINATION
-
批准号:6697453
-
项目类别:
-
资助金额:$31.9万
-
财政年份:2001
-
负责人:Andrea Bottaro
-
依托单位:
REGULATION OF IGH MU LOCUS CLASS SWITCH RECOMBINATION
-
批准号:6845371
-
项目类别:
-
资助金额:$31.9万
-
财政年份:2001
-
负责人:Andrea Bottaro
-
依托单位:
REGULATION OF IGH MU LOCUS CLASS SWITCH RECOMBINATION
-
批准号:6706010
-
项目类别:
-
资助金额:$3.98万
-
财政年份:2001
-
负责人:Andrea Bottaro
-
依托单位:
REGULATION OF IGH MU LOCUS CLASS SWITCH RECOMBINATION
-
批准号:6260412
-
项目类别:
-
资助金额:$34.94万
-
财政年份:2001
-
负责人:Andrea Bottaro
-
依托单位:
REGULATION OF IGH MU LOCUS CLASS SWITCH RECOMBINATION
-
批准号:6497317
-
项目类别:
-
资助金额:$34.94万
-
财政年份:2001
-
负责人:Andrea Bottaro
-
依托单位:
Humoral immunodeficiency in cancer-prone SENCAR mice
-
批准号:6327444
-
项目类别:
-
资助金额:$34.88万
-
财政年份:2001
-
负责人:Andrea Bottaro
-
依托单位:
REGULATION OF IGH MU LOCUS CLASS SWITCH RECOMBINATION
-
批准号:6650930
-
项目类别:
-
资助金额:$0.62万
-
财政年份:2001
-
负责人:Andrea Bottaro
-
依托单位:
REGULATION OF IGH MU LOCUS CLASS SWITCH RECOMBINATION
-
批准号:6628032
-
项目类别:
-
资助金额:$31.9万
-
财政年份:2001
-
负责人:Andrea Bottaro
-
依托单位:
国内基金
海外基金
登录
查看更多内容
基于MFSD2A调控血迷路屏障跨细胞囊泡转运机制的噪声性听力损失防治研究
-
批准号:82371144
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:汪雪玲
-
依托单位:
cGAS-STING激活IFN1反应介导噪声性耳蜗损伤机制研究
-
批准号:82371152
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:冯艳梅
-
依托单位:
基于NLRP3/IL-1β信号探讨α7nAChR介导巨噬细胞—心肌细胞互作在Aβ诱导房颤心房重构中的作用及机制研究
-
批准号:82300356
-
项目类别:青年科学基金项目
-
资助金额:30.00万元
-
批准年份:2023
-
负责人:赵继凯
-
依托单位:
脂肪酸合成通过GDF15/IRS2介导胰岛素抵抗促进血管内皮细胞活化导致脓毒症肺损伤的机制研究
-
批准号:82372203
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:李然然
-
依托单位:
PAX5调控LINE-1转录影响细胞衰老的机制研究
-
批准号:32200603
-
项目类别:青年科学基金项目(C类)
-
资助金额:30.0万元
-
批准年份:2022
-
负责人:张伟娜
-
依托单位:
小鼠肺腺鳞癌转分化类器官模型的建立及表观调控分子机制研究
-
批准号:32100593
-
项目类别:青年科学基金项目(C类)
-
资助金额:30.0万元
-
批准年份:2021
-
负责人:童欣媛
-
依托单位:
雄性线虫特异分泌蛋白F56D2.8调节衰老与寿命的机制研究
-
批准号:32100604
-
项目类别:青年科学基金项目(C类)
-
资助金额:30.0万元
-
批准年份:2021
-
负责人:龚健科
-
依托单位:
KLF5诱导小鼠始发态多能性干细胞向滋养层干细胞转变的作用与机制研究
-
批准号:32100596
-
项目类别:青年科学基金项目(C类)
-
资助金额:30.0万元
-
批准年份:2021
-
负责人:黄颖华
-
依托单位:
PGCLCs介导小鼠多能干细胞始发态向原始态转变的机制研究
-
批准号:32100594
-
项目类别:青年科学基金项目(C类)
-
资助金额:30.0万元
-
批准年份:2021
-
负责人:周纯华
-
依托单位:
NRF2/MFN2/ERS信号异常促进ADSCs衰老和肥大型肥胖皮下脂肪组织胰岛素抵抗的机制研究
-
批准号:32000511
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2020
-
负责人:方佳
-
依托单位: